Company News
Location:
Home
News
Company News
A Resounding Success | Laviana Pharma Concludes its Remarkable Journey at CPHI North America

CPHI North America, the only gathering in the pharmaceutical industry, encompassing the entire spectrum of drug research, production, and packaging, has come to a thrilling close. From May 7th to 9th, 2024. Laviana Pharma took center stage at this esteemed event, showcasing its global business team and engaging with industry peers and esteemed experts from across the globe to explore collaborative opportunities and delve into the forefront of industry trends.


照片优化1.png


Undoubtedly, the North American market stands as the pivotal destination for pharmaceutical raw materials, dictating the course of the entire pharmaceutical landscape. Philadelphia, nestled in the heart of Pennsylvania, ranks as the third largest economic powerhouse on the East Coast, trailing only New York and Chicago, and plays host to an impressive array of top-tier global pharmaceutical companies.


CPHI North America is an indispensable annual exhibition for pharmaceutical professionals, boasting participation from 101 countries and regions, 332 exhibitors, and an astonishing attendance of over 3.500 industry enthusiasts. It serves as an exceptional platform for like-minded professionals and industry experts to expand their global network, explore international markets, and gain unparalleled insights into cutting-edge

advancements.


照片优化3.png


During this momentous exhibition, Laviana Pharma’ research and development team, alongside its accomplished global business team, fervently shared the company’s recent breakthroughs and showcased exemplary case studies. The company’s unwavering dedication to excellence and commitment to delivering exceptional quality and service has garnered acclaim and admiration from clients both at home and abroad.


照片优化2.png


As a steadfast participant in CPHI’s global series, Laviana Pharma remains resolute in its dedication to the CPHI exhibitions. We cordially invite colleagues to schedule early appointments with our esteemed research and business teams, as we join forces to propel the global CDMO industry toward new horizons.